Clinical Trial Update: Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating apatinib combined with paclitaxel as second-line therapy for advanced gastric cancer is underway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN